Immunotherapy for Head and Neck Cancer Treatment
1 Visualizações
• 07/02/23
0
0
Embutir
administrator
Assinantes
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários